Edition:
United Kingdom

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

159.83USD
4:35pm GMT
Change (% chg)

$4.02 (+2.58%)
Prev Close
$155.81
Open
$156.29
Day's High
$160.23
Day's Low
$156.02
Volume
30,561
Avg. Vol
85,137
52-wk High
$160.23
52-wk Low
$95.21

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.39 December 22 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 2 27.02 29.90 24.15 --
Quarter Ending Jun-18 2 39.36 40.30 38.43 --
Year Ending Dec-18 6 166.61 195.40 153.48 204.79
Earnings (per share)
Quarter Ending Mar-18 3 0.39 1.03 0.02 --
Quarter Ending Jun-18 3 0.55 0.57 0.54 --
Year Ending Dec-18 6 2.49 3.98 1.96 4.17
LT Growth Rate (%) 2 27.50 30.00 25.00 48.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 30.91 33.38 2.46 7.96
Quarter Ending Jun-17 24.07 28.00 3.93 16.32
Quarter Ending Mar-17 31.24 29.27 1.97 6.31
Quarter Ending Dec-16 40.33 38.19 2.15 5.33
Quarter Ending Sep-16 23.13 21.62 1.51 6.53

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 27.02 27.02 27.02 24.15 --
Quarter Ending Jun-18 39.36 39.36 39.36 38.43 --
Year Ending Dec-18 166.61 166.59 167.70 171.28 204.79

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 1 0 1 2
Earnings